Overview
Multicenter prospective registry of patients with symptomatic Carpal Tunnel Syndrome treated with Ultrasound Guided Carpal Tunnel Release (CTR-US).
Description
Multicenter prospective registry of patients with symptomatic Carpal Tunnel Syndrome treated with Ultrasound Guided Carpal Tunnel Release (CTR-US) to collect large scale, multidimensional real-world data.
Eligibility
Inclusion Criteria:
- ≥18 years of age
- Clinical diagnosis of unilateral or bilateral CTS
- A clinical decision has been made to perform CTR-US using UltraGuideCTR on one or both hands
- CTS-6 score >12 in the target hand(s)
- Confirmatory diagnostic testing with ultrasound (median nerve cross-sectional area ≥10 mm2 in the proximal carpal tunnel region)
- Prior failure of one or more nonsurgical treatment options (e.g., physical activity modification, bracing, splinting, corticosteroid injection) in the target hand(s)
- Patient agrees to complete follow-up questionnaires over a 24-month period.
- Patient has a valid smart phone number and/or email address to receive and answer follow-up questionnaires
Exclusion Criteria:
- Patient meets any of the contraindications per Instruction For Use (IFU)
- Patient has other medical, social, or psychological conditions that, in the opinion of the investigator, preclude them from completing all registry requirements.